Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

363
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

436
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
436
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

414
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
414
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

470
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Prognosis of acute myocarditis beyond hospitalization: Results of a long-term prospective study.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

Donor- and unit-specific factors influencing hemolysis in stored canine and feline packed red blood cells.

Frontiers in veterinary science·2026
Same author

Cardiac Radiation Dose and Subclinical Coronary Artery Disease Progression after Breast Cancer Radiotherapy: 2-year Cardiac CT Results from the EARLY-HEART Study.

Radiology. Cardiothoracic imaging·2026
Same author

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

JAMA network open·2026
Same author

Differentiating Upper Tract Urothelial Carcinoma with Synchronous or Metachronous Bladder Cancer.

Current issues in molecular biology·2026
Same author

Right Ventricular Metastasis From Rectal Cancer Recurrence.

JACC. Case reports·2026

Related Experiment Video

Updated: Mar 16, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Organization and implementation of a cardio-oncology program.

Manuela Fiuza1, Leonor Ribeiro2, Andreia Magalhães1

  • 1Serviço de Cardiologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte - EPE, Centro Académico Medicina de Lisboa / Centro Cardiovascular da Universidade de Lisboa, Lisboa, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|August 10, 2016
PubMed
Summary

Cancer survivorship is increasing, but so are cardiovascular side effects from treatments. A new field, cardio-oncology, is emerging to manage these complex heart conditions in cancer patients.

Keywords:
CancerCancroCardiotoxicidadeCardiotoxicityCardio‐oncologyChemotherapyCárdio‐oncologiaHeart failureInsuficiência cardíacaQuimioterapiaRadiationRadioterapia

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.8K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.8K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Area of Science:

  • Cardiovascular Medicine
  • Oncology
  • Cardio-Oncology

Background:

  • Cancer therapies have improved survival rates, leading to a growing population of cancer survivors.
  • Increased cancer survival is associated with a rise in adverse cardiovascular effects, particularly in patients with pre-existing heart conditions.
  • Cardiotoxicity, ranging from left ventricular dysfunction to diverse effects from newer therapies, compromises cancer treatment efficacy.

Purpose of the Study:

  • To highlight the growing challenge of cardiotoxicity in cancer patients.
  • To emphasize the need for improved early detection, prevention, and treatment strategies for cancer treatment-related cardiotoxicity.
  • To advocate for a multidisciplinary approach and the development of cardio-oncology programs.

Main Methods:

  • Review of current understanding of cardiotoxicity from conventional and novel cancer therapies.
  • Identification of limitations in current guidelines and screening tools for cardiotoxicity.
  • Emphasis on echocardiography as a key assessment tool.
  • Proposal for a multidisciplinary collaboration involving cardiology, oncology, and radiation therapy.

Main Results:

  • Cardiotoxicity presents diverse cardiovascular effects beyond heart failure, especially with newer cancer treatments.
  • There is a lack of established guidelines and screening tools for cancer treatment-induced cardiotoxicity.
  • Echocardiography is crucial for patient assessment throughout cancer treatment.
  • A multidisciplinary cardio-oncology approach is essential for comprehensive patient care.

Conclusions:

  • Cardio-oncology is an emerging subspecialty addressing cardiovascular complications in cancer patients.
  • Multidisciplinary collaboration and dedicated cardio-oncology programs are vital for managing cardiotoxicity.
  • Further research and training are needed to optimize the care of cancer patients with cardiovascular comorbidities.